Rep. Joanne Shofner
Total votes
3,696
all sessions
Attendance
97%
128 missed
Near the chamber average
With party
86%
of cast votes
Lower than 82% of chamber peers
Bipartisan score
7%
crosses aisle rarely
Higher than 80% of chamber peers
Sponsored
489
bills & resolutions
Higher than 98% of chamber peers
Committees
2
assignments
3,696 roll-call votes
Voting record
Yea
2,764
voted in favor
Nay
847
voted against
Absent
128
missed votes
Total cast
3,696
across all sessions
Crossed party
481
votes against own party
This page
3,696
matching current filters
Bill
Description
Vote
Result
Tally
Date
HB 3449
Relating to the reimbursement of expenses to certain counsel appointed to represent a defendant in a criminal proceeding.
Yea
Passed
135–1
May 13, 2025
HB 2464
Relating to the authority of a municipality to regulate a home-based business.
Yea
Passed
115–15
May 13, 2025
HB 3722
Relating to the height of a structure near certain airspace designated for use by Department of Defense contractors.
Yea
Passed
91–49
May 13, 2025
HB 2253
Relating to the authority to cancel certain elections on a measure to authorize the issuance of bonds. Against party
Nay
Passed
98–38
May 13, 2025
HB 1533
Relating to the system for appraising property for ad valorem tax purposes.
Yea
Passed
137–0
May 13, 2025
HB 1052
Relating to health benefit plan coverage of telemedicine, teledentistry, and telehealth appointments with an originating site or distant site located outside this state. Against party
Nay
Passed
114–26
May 13, 2025
HB 4580
Relating to the exemption from ad valorem taxation of property owned by certain nonprofit corporations and used to promote agriculture, support youth, and provide educational support in the community. Against party
Nay
Passed
102–33
May 13, 2025
HB 4755
Relating to the authority of certain municipalities to use hotel occupancy tax revenue for certain venue projects. Against party
Nay
Passed
96–27
May 13, 2025
SB 2308
Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Yea
Passed
138–1
May 13, 2025
Ask Maddy
·
AI policy assistant
Ask Maddy about Joanne Shofner
Scope: TX
Hi! I can help you understand Joanne Shofner's legislative record. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline